| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 19 | 2025 | 1097 | 1.100 |
Why?
|
| Magnetic Resonance Imaging | 26 | 2010 | 3593 | 0.890 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2025 | 169 | 0.680 |
Why?
|
| Tetralogy of Fallot | 6 | 2025 | 173 | 0.660 |
Why?
|
| Magnetic Resonance Angiography | 10 | 2009 | 157 | 0.610 |
Why?
|
| Pulmonary Artery | 9 | 2007 | 445 | 0.450 |
Why?
|
| Coronary Disease | 3 | 2009 | 622 | 0.440 |
Why?
|
| Stroke Volume | 5 | 2025 | 490 | 0.440 |
Why?
|
| Heart Defects, Congenital | 14 | 2005 | 1840 | 0.410 |
Why?
|
| Aorta, Thoracic | 7 | 2008 | 465 | 0.400 |
Why?
|
| Ventricular Function, Left | 2 | 2025 | 504 | 0.380 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2011 | 138 | 0.330 |
Why?
|
| Computer Graphics | 1 | 2005 | 37 | 0.240 |
Why?
|
| Vasculitis | 1 | 2005 | 45 | 0.230 |
Why?
|
| Computer Security | 1 | 2005 | 27 | 0.230 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 62 | 0.230 |
Why?
|
| Hypertension, Pulmonary | 2 | 2011 | 442 | 0.230 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 71 | 0.220 |
Why?
|
| Confidentiality | 1 | 2005 | 103 | 0.220 |
Why?
|
| Anastomosis, Surgical | 1 | 2005 | 159 | 0.220 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2005 | 138 | 0.220 |
Why?
|
| Documentation | 1 | 2005 | 114 | 0.220 |
Why?
|
| Coronary Circulation | 3 | 2011 | 188 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2010 | 591 | 0.180 |
Why?
|
| Electrocardiography | 9 | 2015 | 918 | 0.180 |
Why?
|
| Aortic Diseases | 1 | 2002 | 166 | 0.170 |
Why?
|
| Heart Failure | 2 | 2010 | 2165 | 0.170 |
Why?
|
| Myocardial Contraction | 4 | 2015 | 235 | 0.160 |
Why?
|
| Aorta | 5 | 2003 | 503 | 0.160 |
Why?
|
| Transposition of Great Vessels | 2 | 2000 | 118 | 0.160 |
Why?
|
| Heart Ventricles | 6 | 2010 | 748 | 0.160 |
Why?
|
| Carotid Arteries | 3 | 2006 | 129 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 5 | 2007 | 142 | 0.150 |
Why?
|
| Humans | 61 | 2025 | 126153 | 0.150 |
Why?
|
| Child | 24 | 2025 | 25112 | 0.140 |
Why?
|
| Ventricular Remodeling | 2 | 2009 | 148 | 0.140 |
Why?
|
| Respiration | 2 | 2003 | 119 | 0.140 |
Why?
|
| Myocardium | 3 | 2015 | 837 | 0.130 |
Why?
|
| Coronary Vessel Anomalies | 3 | 2007 | 283 | 0.130 |
Why?
|
| Aortic Coarctation | 4 | 2001 | 96 | 0.120 |
Why?
|
| Infant | 17 | 2025 | 12803 | 0.120 |
Why?
|
| Cardiac Catheterization | 5 | 2003 | 612 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2008 | 380 | 0.120 |
Why?
|
| Echocardiography, Doppler | 4 | 2003 | 164 | 0.120 |
Why?
|
| Thrombophlebitis | 1 | 1995 | 19 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 225 | 0.110 |
Why?
|
| Collateral Circulation | 1 | 1994 | 40 | 0.110 |
Why?
|
| Female | 30 | 2025 | 68045 | 0.110 |
Why?
|
| Child, Preschool | 17 | 2025 | 14375 | 0.100 |
Why?
|
| Intestine, Small | 1 | 2015 | 286 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 210 | 0.100 |
Why?
|
| Cardiac Volume | 2 | 2011 | 16 | 0.100 |
Why?
|
| Pulmonary Veins | 2 | 2002 | 172 | 0.100 |
Why?
|
| Carotid Artery Diseases | 2 | 2004 | 131 | 0.100 |
Why?
|
| Long QT Syndrome | 1 | 1993 | 83 | 0.090 |
Why?
|
| Regional Blood Flow | 2 | 2003 | 197 | 0.090 |
Why?
|
| Adult | 21 | 2010 | 30315 | 0.090 |
Why?
|
| Eisenmenger Complex | 1 | 2011 | 4 | 0.090 |
Why?
|
| Heart-Assist Devices | 2 | 2010 | 1029 | 0.090 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2011 | 10 | 0.090 |
Why?
|
| Male | 26 | 2025 | 62235 | 0.090 |
Why?
|
| Oral Hygiene | 1 | 2011 | 10 | 0.090 |
Why?
|
| Twins, Conjoined | 2 | 2002 | 30 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 2005 | 0.090 |
Why?
|
| Aptamers, Peptide | 1 | 2010 | 4 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2011 | 37 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 277 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 54 | 0.080 |
Why?
|
| Catheterization | 4 | 1997 | 232 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 755 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 108 | 0.080 |
Why?
|
| Aptamers, Nucleotide | 1 | 2010 | 35 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 2011 | 87 | 0.080 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2010 | 6 | 0.080 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2010 | 37 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 250 | 0.080 |
Why?
|
| Knowledge Bases | 1 | 2010 | 37 | 0.080 |
Why?
|
| Endocarditis | 1 | 2011 | 94 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 121 | 0.080 |
Why?
|
| Vascular Diseases | 3 | 2007 | 149 | 0.080 |
Why?
|
| Angiography | 3 | 1995 | 184 | 0.080 |
Why?
|
| Drug Design | 1 | 2010 | 154 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2001 | 248 | 0.080 |
Why?
|
| Tetrahymena pyriformis | 2 | 1979 | 2 | 0.080 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2011 | 141 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2010 | 172 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 225 | 0.070 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2005 | 40 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 208 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 103 | 0.070 |
Why?
|
| Radiography | 4 | 2005 | 748 | 0.070 |
Why?
|
| RNA Interference | 1 | 2010 | 495 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 278 | 0.070 |
Why?
|
| Tricuspid Valve | 1 | 2008 | 62 | 0.070 |
Why?
|
| Thorax | 4 | 2003 | 69 | 0.070 |
Why?
|
| Vena Cava, Inferior | 3 | 2003 | 98 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2010 | 511 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 1989 | 106 | 0.070 |
Why?
|
| Adolescent | 18 | 2010 | 19986 | 0.070 |
Why?
|
| Pregnancy | 5 | 2011 | 7397 | 0.070 |
Why?
|
| Subclavian Artery | 1 | 2008 | 66 | 0.070 |
Why?
|
| Heart Diseases | 4 | 2008 | 485 | 0.070 |
Why?
|
| Stents | 3 | 2001 | 732 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 73 | 0.070 |
Why?
|
| Infant, Newborn | 14 | 2005 | 8382 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2006 | 10 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2007 | 137 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2006 | 38 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 351 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 88 | 0.060 |
Why?
|
| Ethics, Medical | 1 | 1989 | 399 | 0.060 |
Why?
|
| Image Enhancement | 2 | 2004 | 157 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 539 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2010 | 682 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 126 | 0.060 |
Why?
|
| Endarterectomy, Carotid | 1 | 2006 | 76 | 0.060 |
Why?
|
| Programming Languages | 1 | 2005 | 19 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 314 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1375 | 0.060 |
Why?
|
| Computer Systems | 1 | 2005 | 38 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2009 | 542 | 0.060 |
Why?
|
| Cineangiography | 3 | 1994 | 15 | 0.060 |
Why?
|
| Prednisone | 1 | 2005 | 238 | 0.060 |
Why?
|
| Proteins | 1 | 2010 | 1020 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 142 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2009 | 889 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 116 | 0.050 |
Why?
|
| Systole | 3 | 2010 | 186 | 0.050 |
Why?
|
| Infant, Premature, Diseases | 2 | 1987 | 236 | 0.050 |
Why?
|
| Abdomen | 2 | 2003 | 131 | 0.050 |
Why?
|
| Aspirin | 1 | 2005 | 201 | 0.050 |
Why?
|
| Contrast Media | 2 | 2006 | 450 | 0.050 |
Why?
|
| Vectorcardiography | 1 | 2003 | 3 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2003 | 800 | 0.050 |
Why?
|
| Myocardial Reperfusion | 1 | 2003 | 52 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 5 | 1996 | 243 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2009 | 858 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2004 | 5107 | 0.050 |
Why?
|
| Dizziness | 1 | 2002 | 26 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2002 | 62 | 0.050 |
Why?
|
| Aortography | 3 | 1997 | 148 | 0.050 |
Why?
|
| Heart Aneurysm | 1 | 2002 | 33 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2015 | 1385 | 0.050 |
Why?
|
| Bundle-Branch Block | 1 | 2002 | 38 | 0.050 |
Why?
|
| Abnormalities, Multiple | 2 | 2000 | 966 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2001 | 114 | 0.040 |
Why?
|
| Biomarkers | 1 | 2010 | 3150 | 0.040 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2002 | 108 | 0.040 |
Why?
|
| Scimitar Syndrome | 1 | 2002 | 52 | 0.040 |
Why?
|
| Sinus of Valsalva | 1 | 2001 | 32 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 541 | 0.040 |
Why?
|
| Oximetry | 1 | 2001 | 174 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2000 | 92 | 0.040 |
Why?
|
| Pericardial Effusion | 2 | 1991 | 72 | 0.040 |
Why?
|
| Prosthesis Implantation | 1 | 2001 | 155 | 0.040 |
Why?
|
| Tourniquets | 1 | 1999 | 11 | 0.040 |
Why?
|
| Aortic Rupture | 1 | 2001 | 103 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 1979 | 6 | 0.040 |
Why?
|
| Acetylglucosaminidase | 1 | 1979 | 12 | 0.040 |
Why?
|
| Infant, Premature | 1 | 1985 | 823 | 0.040 |
Why?
|
| Fabry Disease | 1 | 1999 | 18 | 0.040 |
Why?
|
| Bacteriolysis | 1 | 1979 | 6 | 0.040 |
Why?
|
| Heart Atria | 1 | 2002 | 327 | 0.040 |
Why?
|
| Organotechnetium Compounds | 1 | 1999 | 10 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 1979 | 16 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 25 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 97 | 0.040 |
Why?
|
| Diastole | 2 | 2010 | 168 | 0.040 |
Why?
|
| Prenatal Diagnosis | 2 | 2001 | 627 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 159 | 0.040 |
Why?
|
| Middle Aged | 12 | 2010 | 27403 | 0.030 |
Why?
|
| Virus Diseases | 1 | 1999 | 267 | 0.030 |
Why?
|
| Observer Variation | 2 | 2004 | 306 | 0.030 |
Why?
|
| Angioplasty, Balloon | 2 | 1988 | 127 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 999 | 0.030 |
Why?
|
| Dogs | 3 | 1992 | 602 | 0.030 |
Why?
|
| Heart | 2 | 1989 | 645 | 0.030 |
Why?
|
| Mutation | 2 | 2007 | 5933 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 2878 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 225 | 0.030 |
Why?
|
| Veins | 1 | 1995 | 99 | 0.030 |
Why?
|
| Pedigree | 2 | 2009 | 1655 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 1823 | 0.020 |
Why?
|
| Propranolol | 1 | 1993 | 110 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 1992 | 11 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1994 | 950 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1999 | 903 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2008 | 3306 | 0.020 |
Why?
|
| Rabbits | 1 | 1992 | 640 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2005 | 789 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 1993 | 183 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1993 | 270 | 0.020 |
Why?
|
| Cor Triatriatum | 1 | 1990 | 10 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 1993 | 208 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Animals | 7 | 2015 | 33235 | 0.020 |
Why?
|
| United States | 1 | 2005 | 11191 | 0.020 |
Why?
|
| Dystrophin | 1 | 2009 | 41 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 125 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 151 | 0.020 |
Why?
|
| Paternalism | 1 | 1989 | 30 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2004 | 6582 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 436 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 247 | 0.020 |
Why?
|
| Spleen | 1 | 1989 | 251 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1979 | 422 | 0.020 |
Why?
|
| Time Factors | 4 | 2009 | 6030 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 274 | 0.020 |
Why?
|
| Mitral Valve | 2 | 1987 | 248 | 0.020 |
Why?
|
| Atrial Septum | 1 | 2008 | 19 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 83 | 0.020 |
Why?
|
| Prospective Studies | 3 | 1999 | 6178 | 0.020 |
Why?
|
| Diverticulum | 1 | 2008 | 27 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 758 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 276 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 639 | 0.020 |
Why?
|
| Mitral Valve Stenosis | 1 | 1987 | 34 | 0.020 |
Why?
|
| Indomethacin | 1 | 1987 | 81 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2008 | 112 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 673 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2008 | 176 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1026 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 622 | 0.020 |
Why?
|
| Iron | 1 | 1989 | 295 | 0.020 |
Why?
|
| Trachea | 1 | 2008 | 204 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1221 | 0.020 |
Why?
|
| Aged | 7 | 2004 | 20078 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 364 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1987 | 166 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 370 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1989 | 428 | 0.010 |
Why?
|
| Sternum | 1 | 1985 | 50 | 0.010 |
Why?
|
| Pravastatin | 1 | 2004 | 21 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 782 | 0.010 |
Why?
|
| Heptanoic Acids | 1 | 2004 | 74 | 0.010 |
Why?
|
| Simvastatin | 1 | 2004 | 75 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1988 | 441 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1067 | 0.010 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1984 | 64 | 0.010 |
Why?
|
| Heart Septum | 2 | 1986 | 46 | 0.010 |
Why?
|
| Ductus Arteriosus | 1 | 1984 | 61 | 0.010 |
Why?
|
| Coronary Angiography | 2 | 2000 | 434 | 0.010 |
Why?
|
| Pyrroles | 1 | 2004 | 181 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 2555 | 0.010 |
Why?
|
| Coronary Aneurysm | 1 | 2003 | 31 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 3604 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1982 | 122 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 1783 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2004 | 238 | 0.010 |
Why?
|
| Liver | 1 | 1989 | 1767 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2001 | 37 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2002 | 950 | 0.010 |
Why?
|
| Calcinosis | 1 | 2002 | 183 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 1059 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 4894 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1989 | 3423 | 0.010 |
Why?
|
| Glycosides | 1 | 1979 | 10 | 0.010 |
Why?
|
| alpha-Galactosidase | 1 | 1999 | 20 | 0.010 |
Why?
|
| Glycerol Kinase | 1 | 1999 | 19 | 0.010 |
Why?
|
| Glycolipids | 1 | 1999 | 33 | 0.010 |
Why?
|
| Cyanosis | 1 | 1999 | 43 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1979 | 298 | 0.010 |
Why?
|
| Arm | 1 | 1999 | 72 | 0.010 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1999 | 61 | 0.010 |
Why?
|
| Hydrolases | 1 | 1999 | 60 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1978 | 11 | 0.010 |
Why?
|
| Culture Media | 1 | 1979 | 174 | 0.010 |
Why?
|
| Cell Wall | 1 | 1979 | 41 | 0.010 |
Why?
|
| Risk Factors | 1 | 1993 | 10376 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1979 | 209 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 1996 | 16831 | 0.010 |
Why?
|
| Streptococcus | 1 | 1979 | 61 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 3258 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 2110 | 0.010 |
Why?
|
| X Chromosome | 1 | 1999 | 332 | 0.010 |
Why?
|
| Ethanol | 1 | 1979 | 159 | 0.010 |
Why?
|
| Species Specificity | 1 | 1979 | 520 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 1639 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 1999 | 12393 | 0.010 |
Why?
|
| Lysosomes | 1 | 1979 | 250 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 2176 | 0.010 |
Why?
|
| Dobutamine | 1 | 1997 | 55 | 0.010 |
Why?
|
| Constriction, Pathologic | 2 | 1988 | 223 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 485 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1996 | 65 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 1997 | 132 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 2012 | 0.010 |
Why?
|
| Motion Pictures | 1 | 1994 | 4 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1993 | 53 | 0.010 |
Why?
|
| Recurrence | 2 | 1988 | 1408 | 0.010 |
Why?
|
| Equipment Design | 1 | 1993 | 585 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1991 | 54 | 0.010 |
Why?
|
| Swine | 1 | 1993 | 1160 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1989 | 21 | 0.000 |
Why?
|
| Hemochromatosis | 1 | 1989 | 37 | 0.000 |
Why?
|
| Ferritins | 1 | 1989 | 104 | 0.000 |
Why?
|
| Esophagus | 1 | 1990 | 229 | 0.000 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1990 | 179 | 0.000 |
Why?
|
| Stainless Steel | 1 | 1988 | 5 | 0.000 |
Why?
|
| Electrodes | 1 | 1988 | 84 | 0.000 |
Why?
|
| Venae Cavae | 1 | 1987 | 11 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1989 | 285 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1987 | 102 | 0.000 |
Why?
|
| Color | 1 | 1986 | 34 | 0.000 |
Why?
|
| Movement | 1 | 1988 | 155 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1988 | 147 | 0.000 |
Why?
|
| Autopsy | 1 | 1986 | 112 | 0.000 |
Why?
|
| Syndrome | 1 | 1986 | 1114 | 0.000 |
Why?
|
| Aortic Valve | 1 | 1986 | 410 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1988 | 1302 | 0.000 |
Why?
|
| Palliative Care | 1 | 1986 | 437 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1991 | 4435 | 0.000 |
Why?
|